Stock Region Penny Picks
These 9 Stocks You Can’t Ignore.
These 9 Stocks You Can’t Ignore
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: Heads up! The information in this newsletter is for entertainment and informational purposes only. I’m just a trader sharing my thoughts, not a financial advisor. Always do your own research and due diligence before making any investment decisions. Investing involves risk, and you could lose money. Don’t trade based on this newsletter alone.
What a day in the markets! We saw some massive moves and announcements that could be game-changers for a few companies. It’s the kind of day that reminds you why we watch the tape so closely. Let’s break down the tickers that lit up my screen today.
The Heavy Hitters & Big Movers
$PBM - Psyence BioMed
This one feels significant. Psyence announced a breakthrough in creating a pharmaceutical-grade supply of Ibogaine. Why does this matter? They’re positioning themselves to supply this compound for clinical trials and therapeutic use worldwide. The psychedelic medicine space is gaining legitimacy, and having a reliable supply chain is everything. This could be a foundational move for them. I’m keeping a very close eye on $PBM to see how they capitalize on this.
$TC - Token Cat Limited
A $1 billion agreement? You read that right. Token Cat signed a massive cross-border sales deal with Ouyi Industrial, citing strong demand. Honestly, a billion-dollar deal for a company like this is staggering. It makes you wonder about the scale of their operations and just how “strong” that demand really is. This news is almost too good to be true, so while it’s incredibly exciting, We’re watching with a healthy dose of caution. Huge potential, but also huge questions.
$PSTV - Plus Therapeutics
This is a huge win for Plus Therapeutics. They secured a national coverage agreement with Humana for their CNSide® assay, which helps detect cancer in cerebrospinal fluid. Getting coverage from a major insurer like Humana is a critical step for any medical device or test. It validates the product and, more importantly, opens up a clear revenue path. This feels like a solid, fundamental step forward for the company.
Earnings, Strategy, & Future Paths
$MAGN - Magnera
Magnera reported their Q4 2025 results, and the numbers are interesting. They posted $839M in net sales, but only $10M in operating income. The real headline for me is the record $96M in cash from operations. It shows they can generate cash, which is king. The low operating income suggests their margins might be thin, but strong cash flow gives them flexibility. A mixed bag, but the cash part is what has my attention.
$SGBX - Safe & Green Holdings
A year under new leadership, and $SGBX is outlining a new energy strategy. Strategic shifts like this can be pivotal. It often means the company is trimming the fat and focusing on what works. The devil is in the details, which we don’t fully have yet. But a new, “integrated” strategy sounds promising. I’m waiting for more concrete plans before getting too excited, but this is a signal that change is underway.
$AUID - authID
authID is teaming up with NVIDIA. In 2025, you hear “AI,” and your ears perk up. You hear “NVIDIA,” and you pay even closer attention. $AUID is joining NVIDIA Connect to work on enterprise and AI agent security. This is a classic “riding the coattails” move, but in the best way possible. Aligning with a giant like NVIDIA gives them credibility and access. It’s a smart partnership in the hottest sector on the planet.
$BNKK - BONK INC
The company is making a bold claim: they are on a path to positive cash flow in the coming quarters. This is exactly what you want to hear from a company that might have been burning cash. They’re broadcasting confidence. Now, they have to deliver. If they can actually pull it off and stop the bleed, it could completely change the narrative around the stock. This is a “prove it” story for me.
Future-Forward Agreements
$SMTK - Smartkem & Jericho Energy Ventures
An all-stock merger to create a U.S.-owned, AI-focused infrastructure company? This one has buzzwords written all over it. Smartkem and Jericho are extending their letter of intent. Mergers can be messy, but the vision here is compelling—combining tech with energy to build AI infrastructure. It’s a high-concept play, and the fact they are extending the LOI means they are still serious about getting it done. Definitely one for the long-term watchlist.
$NVVE - Nuvve New Mexico
Nuvve signed a deal with the City of Socorro and its electric co-op to advance electrification and grid resilience. This is the kind of nuts-and-bolts news that can lead to steady, long-term growth. It’s not as flashy as a billion-dollar deal, but it represents real-world application and adoption of their technology. These local and municipal partnerships are how you build a nationwide footprint. Solid, foundational, and smart.
That’s the wrap for today. What a mix of stories! Keep your research sharp and your eyes on the charts.
Happy trading,
The Stock Region Team
Final reminder: This newsletter contains opinions and is for informational purposes only. It is not intended to be investment advice. Seek a duly licensed professional for investment advice. Trading and investing can be risky, and you should never invest more than you are willing to lose.